CD19 can regulate B lymphocyte signal transduction independent of complement activation

Journal of Immunology

Volumn 167, Issue 6, 2001, Pages 3190-3200

  Hasegawa, M ^a   Fujimoto, M ^a   Poe, J C ^a   Steeber, D A ^a   Tedder, T F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C3D RECEPTOR; MEMBRANE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0035884992     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.6.3190     Document Type: Article

References (72)

1. The CD19/21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity
2. The role of complement and complement receptors in induction and regulation of immunity
3. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex
4. Intersection of the complement and immune systems: A signal transduction complex of the B lymphocyte containing complement receptor type 2 and CD19
5. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules
6. The CD19/CD21 signal transduction complex of B lymphocytes
7. The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity
8. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes: A new member of the immunoglobulin supeffamily
9. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity
10. The signaling activity of murine CD19 is regulated during B cell development
11. The CD19 signal transduction complex of B lymphocytes: Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu-13
12. 13 complex requires the cytoplasmic domain of CD19
13. CD19 regulates B lymphocyte responses to transmembrane signals
14. CD19 regulates Src-family protein tyrosine kinase activation in B lymphocytes through processive amplification
15. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation
16. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase
17. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin
18. CD19 as a membrane-anchored adaptor protein of B lymphocytes: Costimulation of lipid and protein kinases by recruitment of Vav
19. Structure and domain organization of the CD19 antigen of human, mouse and guinea pig B lymphocytes: Conservation of the extensive cytoplasmic domain
20. CD19 expression levels regulate B lymphocyte development: Human CD19 restores normal function in mice lacking endogenous CD19
21. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes
22. Expression of C3d receptors during human B cell differentiation: Immunofluorescence analysis with the HB-5 monoclonal antibody
23. Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes
24. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: Homology with the receptor for fragments C3b and C4b of the third and fourth components of complement
25. A molecular and immunochemical characterization of mouse CR2: Evidence for a single gene model of mouse complement receptors I and 2
26. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1
27. Structure and function of the complement receptors. CR1 (CD35) and CR2 (CD21)
28. -/- mice restores humoral immune function
29. Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
30. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice
31. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation
32. Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B lymphocyte development
33. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen
34. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
35. Humoral response to herpes simplex virus is complement-dependent
36. In vivo inhibition of the antibody response to a complement receptor-specific monoclonal antibody
37. Suppression of the immune response by a soluble complement receptor of B lymphocytes
38. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction
39. Regulation of the B cell response to T-dependent antigens by classical pathway complement
40. Studies of group B streptococcal infection in mice deficient in complement C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity
41. A critical role for complement in maintenance of self-tolerance
42. The role of complement in B cell activation and tolerance
43. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2
44. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response
45. Antibody response to a T-dependent antigen requires B cell expression of complement receptors
46. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses
47. Dependence of germinal center B cells on expression of CD21/CD35 for survival
48. Molecular mapping of functional domains of the leukocyte receptor for endothelium, LAM-1
49. Monoclonal antibodies to mouse complement receptor type 1 (CR1): Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative
50. Mouse complement receptors type I (CR1; CD35) and type 2 (CR2; CD21): Expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice
51. Quantitative genetic variation in CD19 expression correlates with autoimmunity in mice and humans
52. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus
53. Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE)
54. Genetic susceptibility and class III complement genes
55. Multiple defects in the immune system of Lyn-deficient mice. Culminating in autoimmune disease
56. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice
57. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation
58. Normal lymphocyte development but delayed humoral immune response in CD81-null mice
59. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81
60. Impaired CD19 expression and signaling, enhanced antibody response to type II T-independent antigen and reduction of B-1 cells in CD81-deficient mice
61. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes
62. Mice carrying a CD20 gene disruption
63. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection
64. -/- mice: Enhanced affinity maturation but impaired antibody persistence
65. Regulation of humoral immune responses by CD21/35
66. -/- mice is rescued by adjuvants without improvement in germinal center development
67. Mapping of the Epstein-Barr virum and C3dg binding sites to a common domain on complement receptor type 2
68. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization and viral infection
69. Gene targeting vectors for mammalian cells
70. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral responses
71. CD21 augments antigen presentation in immune individuals
72. CD19 and CD22 regulate a B lymphocyte signal transduction pathway that contributes to autoimmunity